Staff Services Student Enterprise

Biotechnology

Accelerate business growth and deliver environmental benefits by harnessing the novel biotechnologies created by researchers at the University of Edinburgh.

At the University of Edinburgh we use biotechnology to redesign living systems and transform them into biofactories for the more sustainable manufacture of chemicals. Our activities in this space include engineering microbes to produce sustainable alternatives to petrochemicals and novel sources of food, clean up contaminated sites (bioremediation), recover valuable components (resource efficiency), and recycle valuable waste metal (biomining). We also use natural and engineered biocatalysts (enzymes) to generate high-value products, for example drug intermediates, from sustainable building blocks and produce biosensors to monitor environmental pollution.

The University harnesses world-class research capabilities in biological sciences, chemistry, engineering, geosciences, informatics and physics, and we provide our commercial partners with tailored expertise to deliver the environmental benefits, innovative new products, enhanced performance, resource conservation and reduced costs promised by Industrial Biotechnology.

Key areas of expertise

Centre for Engineering Biology

The Centre for Engineering Biology spans biology, chemistry, physics, informatics, social sciences, engineering, maths, medicine and veterinary sciences. Our researchers explore fundamental biological questions about living cells and systems and apply these insights – often in collaboration with industry – to create innovations for many markets including personal and home care, food and drink, flavours and fragrances, advanced and functional materials, agriculture, the environment, and medicine and healthcare.

For more information contact Dr Emma Elliott.


Biocompatible chemistry

Merging the flexibility and scope offered by modern synthetic chemistry with the sustainable and programmable features of engineering biology, biocompatible chemistry aims to harness the best of both worlds to drive a green chemical industry.

For more information, contact John.Morrow@ei.ed.ac.uk.


Edinburgh Genome Foundry

A fully automated platform to design and assemble DNA up to chromosome length, the Genome Foundry is at the forefront of animal and human health research. It has the capability to rapidly build and test thousands of genetic constructs for academic and industrial customers to equip cells with new or improved functionalities.

For more information, contact Cameron Chalmers.


Responsible research and innovation (RRI)

The engineering of mammalian systems opens up novel questions for social scientific research. Our leading group of social scientists specialise in engineering biology and collaborate with the Centre for Engineering Biology to foster the design and implementation of sustainable and socially conscious research and innovation.

03 Oct 2024
News  
Spinout Resolution Therapeutics announces £63.5 million Series B financing
Biotechnology
Startups and spinouts
 
Using CRISPR as an activator to target promoters of long non-coding RNAs
Biotechnology
Medical technologies
Therapeutics
05 Jun 2024
News  
New macrophage cell therapy shows promise as first advanced liver disease treatment
Biotechnology
Therapeutics
Tissue regeneration and repair
Technology  
Antisense oligonucleotides for ALS
Novel treatment of neurodegenerative diseases with accompanying TDP-43 proteinopathy
Biotechnology
Medical technologies
Case Study  
Planet vs Plastics
Biotechnology
Circular economy
People, Places and Planet
Sustainability
Case Study  
Chasing the blues with ScotBio
Biotechnology
Food and drink
Genotype to phenotype
Case Study  
Bacteria serves tasty solution to plastic crisis
Biotechnology
People, Places and Planet
Sustainability
Technology  
Identifying structurally stable peptides
A new method for diagnostics and therapeutics development
Biotechnology
Therapeutics
Vaccines
Technology  
Cobalt oxide nanoparticles
An alternative vaccine adjuvant
Biotechnology
Vaccines
Technology  
Engineered reprogramming factors for iPSC generation
A series of engineered molecules that retain a highly specific ability to reprogram adult or fully differentiated cells into pluripotent stem cells only.
Biotechnology
Clinical sciences
Technology  
3D printed body-on-chip predicts human drug distribution
A novel 3D-printed device that could replace the need for drug and chemical safety testing on animals
Biotechnology
Medical technologies
Technology  
FaTTy – a foundational cell line for cellular agriculture
Animals & Agriculture
Biotechnology
Case Study  
Collaborative research in predictive biomarkers
Biotechnology
Clinical sciences
Case Study  
Resolution Therapeutics
Bench to Bedside
Biotechnology
Therapeutics
Tissue regeneration and repair
Case Study  
MiAlgae: fish-free omega-3
Biotechnology
Circular economy
Food and drink
People, Places and Planet
Startups and spinouts
18 Aug 2022
News  
MiAlgae secures multi-million-pound funding
Biotechnology
Circular economy
Startups and spinouts
17 May 2022
News  
Old College Capital joins £1m investment in University startup ŌGI Bio
Investment
12 Jan 2022
News  
GHO Capital invests in cell therapy spinout RoslinCT
Bench to Bedside
Biotechnology
Startups and spinouts
Therapeutics
02 Apr 2021
News  
£8.7m collaboration seeks better route to modern medicines
Biotechnology
Case Study  
Mentholatum: how to improve the nation’s No 1? Here’s the rub… 
Biotechnology